Completion of the pre-clinical testing of the GROSSO® implant

This represents an important milestone in the development of our company moving from pre-clinical stage to the clinical stage with our first product.

Recornea, in collaboration with ISO13485 certified laboratories completed the pre-clinical testing of the GROSSO® implant. These tests included mechanical testing, MRI safety and compatibility, cytotoxicity, sensitization, intracutaneous reactivity, chemical and toxicological evaluations, plus a rabbit study up to 3-months follow-up.

After the completion of the pre-clinical testing, the reports were prepared for submission to get authorization to conduct the First In Human clinical trial of the GROSSO® implant.